#scleroderma resultados de búsqueda

We are honored to welcome our esteemed Scleroderma Senior Consultant, prof.Sindhu Johnson, on her first visit to Saudi Arabia @sindhuJohnson5 #SSRC2025 #Scleroderma @sheikhaifa @ssrsa_org

RoaaRoa's tweet image. We are honored to welcome our esteemed Scleroderma Senior Consultant, prof.Sindhu Johnson, on her first visit to Saudi Arabia
@sindhuJohnson5
#SSRC2025
#Scleroderma @sheikhaifa
@ssrsa_org

Hey everyone! Today is #WorldSclerodermaDay I’m raising awareness about this debilitating disease! I’m in my 4th year. Don’t give up hope! We will find a cure. I’m happy to be thriving. Thanks for the love! ❤️🙏🏼#scleroderma

ClaireDeVille3's tweet image. Hey everyone! Today is #WorldSclerodermaDay I’m raising awareness about this debilitating disease! I’m in my 4th year. Don’t give up hope! We will find a cure. I’m happy to be thriving. Thanks for the love! ❤️🙏🏼#scleroderma

Biologic Therapy for Refractory Juvenile Scleroderma” by Dr. Munirah Al Marri was accepted at #ACR25 – Chicago 🇺🇸! The world’s main rheumatology conference, covering both adult & pediatric advances. A proud step forward in improving care for young patients. #Scleroderma

Drasiri1000's tweet image. Biologic Therapy for Refractory Juvenile Scleroderma” by Dr. Munirah Al Marri
was accepted at #ACR25 – Chicago 🇺🇸!

The world’s main rheumatology conference, covering both adult & pediatric advances.
A proud step forward in improving care for young patients. 

#Scleroderma…

Excited to present data from RESET-SSc in #scleroderma #eular2025. CAR-T was well tolerated with beneficial effects on skin/ FVC. Exciting data on U-M IIS with LN bx showing complete depletion of B cells at 3 weeks and NFC showing normalization of capillary density and size

sclerodermaUM's tweet image. Excited to present data from RESET-SSc in #scleroderma #eular2025. CAR-T was well tolerated with beneficial effects on skin/ FVC. Exciting data on U-M IIS with LN bx showing complete depletion of B cells at 3 weeks and NFC showing normalization of capillary density and size
sclerodermaUM's tweet image. Excited to present data from RESET-SSc in #scleroderma #eular2025. CAR-T was well tolerated with beneficial effects on skin/ FVC. Exciting data on U-M IIS with LN bx showing complete depletion of B cells at 3 weeks and NFC showing normalization of capillary density and size
sclerodermaUM's tweet image. Excited to present data from RESET-SSc in #scleroderma #eular2025. CAR-T was well tolerated with beneficial effects on skin/ FVC. Exciting data on U-M IIS with LN bx showing complete depletion of B cells at 3 weeks and NFC showing normalization of capillary density and size
sclerodermaUM's tweet image. Excited to present data from RESET-SSc in #scleroderma #eular2025. CAR-T was well tolerated with beneficial effects on skin/ FVC. Exciting data on U-M IIS with LN bx showing complete depletion of B cells at 3 weeks and NFC showing normalization of capillary density and size

Excited to present WIN #scleroderma #eular2025. This slide highlights the opportunities in drug development in SSc. Come and join on Saturday 6/14 at 9 AM CET.

sclerodermaUM's tweet image. Excited to present  WIN  #scleroderma #eular2025. This slide highlights the opportunities in drug development in  SSc. Come and join on Saturday 6/14 at 9 AM CET.

Delighted to present the @bmsnews data on #scleroderma #eular2025. Breakfree-1 data showing CAR-T is well tolerated with beneficial effects on skin and FVC and composite endpoint, the revised CRISS.

sclerodermaUM's tweet image. Delighted to present the @bmsnews data on #scleroderma #eular2025. Breakfree-1 data showing CAR-T is well tolerated with beneficial effects on skin and FVC and composite endpoint, the revised CRISS.
sclerodermaUM's tweet image. Delighted to present the @bmsnews data on #scleroderma #eular2025. Breakfree-1 data showing CAR-T is well tolerated with beneficial effects on skin and FVC and composite endpoint, the revised CRISS.
sclerodermaUM's tweet image. Delighted to present the @bmsnews data on #scleroderma #eular2025. Breakfree-1 data showing CAR-T is well tolerated with beneficial effects on skin and FVC and composite endpoint, the revised CRISS.

🧵1/ 👁 Ever wanted to see autoimmune Microvascular dysfunction in action? Nailfold Videocapillaroscopy (NVC) gives us a live look into systemic vascular health. A powerful, non-invasive window for early diagnosis in CTDs. Let’s walk through what it reveals in #Scleroderma.…

IlliasulK's tweet image. 🧵1/
👁 Ever wanted to see autoimmune Microvascular dysfunction in action?

Nailfold Videocapillaroscopy (NVC) gives us a live look into systemic vascular health. A powerful, non-invasive window for early diagnosis in CTDs.

Let’s walk through what it reveals in #Scleroderma.…

🆕CD19 CAR T Cell treatment -A potentially promising future treatment in #SLE #scleroderma #myositis -Needs close collaboration with haematology Great explanation by @chriswincup #ACR24 #Lupus #SystemicSclerosis #IIM

gurdeep_dulay's tweet image. 🆕CD19 CAR T Cell treatment

-A potentially promising future treatment in #SLE #scleroderma #myositis 

-Needs close collaboration with haematology

Great explanation by @chriswincup #ACR24  #Lupus #SystemicSclerosis #IIM

2 years ago,I was invited onto @BBCSheffield Paulette's show to talk about my #scleroderma I've kindly been invited back on to talk about allsorts this Wednesday morning! Wish me luck !!

sclerodermasara's tweet image. 2 years ago,I was invited onto @BBCSheffield Paulette's show to talk about my #scleroderma 
I've kindly been invited back on to talk about allsorts this Wednesday morning! Wish me luck !!

The 3rd #Scleroderma_preceptorship_program The journey of enhancing and optimizing the care of #Scleroderma patients in Saudi Arabia continues to show more promise 💐 Big thanks to: Patients, attendees, speakers and chairpersons @ssrsa_org for facilitating @Boehringer

WaleedHafiz786's tweet image. The 3rd #Scleroderma_preceptorship_program 

The journey of enhancing and optimizing the care of #Scleroderma patients in Saudi Arabia continues to show more promise 💐

Big thanks to: 
Patients, attendees, speakers and chairpersons

@ssrsa_org for facilitating 
@Boehringer…
WaleedHafiz786's tweet image. The 3rd #Scleroderma_preceptorship_program 

The journey of enhancing and optimizing the care of #Scleroderma patients in Saudi Arabia continues to show more promise 💐

Big thanks to: 
Patients, attendees, speakers and chairpersons

@ssrsa_org for facilitating 
@Boehringer…
WaleedHafiz786's tweet image. The 3rd #Scleroderma_preceptorship_program 

The journey of enhancing and optimizing the care of #Scleroderma patients in Saudi Arabia continues to show more promise 💐

Big thanks to: 
Patients, attendees, speakers and chairpersons

@ssrsa_org for facilitating 
@Boehringer…
WaleedHafiz786's tweet image. The 3rd #Scleroderma_preceptorship_program 

The journey of enhancing and optimizing the care of #Scleroderma patients in Saudi Arabia continues to show more promise 💐

Big thanks to: 
Patients, attendees, speakers and chairpersons

@ssrsa_org for facilitating 
@Boehringer…

We partnered with Northwestern Medicine Rheumatology, Northwestern Medicine Digestive Health Institute and the Scleroderma Foundation of Greater Chicago for an educational symposium on the latest developments in #scleroderma research and multidisciplinary management. Anthony…

NM_Lung's tweet image. We partnered with Northwestern Medicine Rheumatology, Northwestern Medicine Digestive Health Institute and the Scleroderma Foundation of Greater Chicago for an educational symposium on the latest developments in #scleroderma research and multidisciplinary management. 

Anthony…
NM_Lung's tweet image. We partnered with Northwestern Medicine Rheumatology, Northwestern Medicine Digestive Health Institute and the Scleroderma Foundation of Greater Chicago for an educational symposium on the latest developments in #scleroderma research and multidisciplinary management. 

Anthony…
NM_Lung's tweet image. We partnered with Northwestern Medicine Rheumatology, Northwestern Medicine Digestive Health Institute and the Scleroderma Foundation of Greater Chicago for an educational symposium on the latest developments in #scleroderma research and multidisciplinary management. 

Anthony…
NM_Lung's tweet image. We partnered with Northwestern Medicine Rheumatology, Northwestern Medicine Digestive Health Institute and the Scleroderma Foundation of Greater Chicago for an educational symposium on the latest developments in #scleroderma research and multidisciplinary management. 

Anthony…

🎊 Congratulations to Dr @Huda_Alfaris on the successful completion of the @UofTRheum #Scleroderma Fellowship! @SchroederInst @UHN_Research @SclerodermaCAN @CSRG2022

SindhuJohnson5's tweet image. 🎊 Congratulations to Dr @Huda_Alfaris on the successful completion of the @UofTRheum #Scleroderma Fellowship! @SchroederInst @UHN_Research @SclerodermaCAN @CSRG2022

While NSIP & UIP are common patterns on HRCT, COP, LIP & DIP can occur in #Scleroderma-ILD. Neither NSIP nor UIP are independent predators of survival. @HanaRheum #EULAR2025

SindhuJohnson5's tweet image. While NSIP & UIP are common patterns on HRCT, COP, LIP & DIP can occur in #Scleroderma-ILD. Neither NSIP nor UIP are independent predators of survival. @HanaRheum #EULAR2025

Prophylactic ACEi in #Scleroderma? No benefit, worse outcomes in renal crisis! #Rheumatology #MedTwitter #BSR25

LastManStand85's tweet image. Prophylactic ACEi in #Scleroderma?

No benefit, worse outcomes in renal crisis!

#Rheumatology #MedTwitter #BSR25

#PFFSummit: Donna Dinkin, DrPH, a PFF patient ambassador with #Scleroderma-associated #InterstitialLungDisease (ILD), speaking Nov. 14 at the 2025 @PFFORG Summit in Chicago. Image & quote taken by Senior Correspondent, @LLuxner. #RareDisease #PulmonaryFibrosis #MedTwitter

RareDisease_Adv's tweet image. #PFFSummit: Donna Dinkin, DrPH, a PFF patient ambassador with #Scleroderma-associated #InterstitialLungDisease (ILD), speaking Nov. 14 at the 2025 @PFFORG Summit in Chicago.

Image & quote taken by Senior Correspondent, @LLuxner.

#RareDisease #PulmonaryFibrosis #MedTwitter

Our latest #scleroderma slide deck and literature highlights are now available on the #SclerodermaForum! Stay up to date with the newest research and clinical insights. Access them for free today: 🔗ow.ly/lVvn50XrEVV

ScleroForum's tweet image. Our latest #scleroderma slide deck and literature highlights are now available on the #SclerodermaForum! 

Stay up to date with the newest research and clinical insights. Access them for free today: 🔗ow.ly/lVvn50XrEVV

We partnered with Northwestern Medicine Rheumatology, Northwestern Medicine Digestive Health Institute and the Scleroderma Foundation of Greater Chicago for an educational symposium on the latest developments in #scleroderma research and multidisciplinary management. Anthony…

NM_Lung's tweet image. We partnered with Northwestern Medicine Rheumatology, Northwestern Medicine Digestive Health Institute and the Scleroderma Foundation of Greater Chicago for an educational symposium on the latest developments in #scleroderma research and multidisciplinary management. 

Anthony…
NM_Lung's tweet image. We partnered with Northwestern Medicine Rheumatology, Northwestern Medicine Digestive Health Institute and the Scleroderma Foundation of Greater Chicago for an educational symposium on the latest developments in #scleroderma research and multidisciplinary management. 

Anthony…
NM_Lung's tweet image. We partnered with Northwestern Medicine Rheumatology, Northwestern Medicine Digestive Health Institute and the Scleroderma Foundation of Greater Chicago for an educational symposium on the latest developments in #scleroderma research and multidisciplinary management. 

Anthony…
NM_Lung's tweet image. We partnered with Northwestern Medicine Rheumatology, Northwestern Medicine Digestive Health Institute and the Scleroderma Foundation of Greater Chicago for an educational symposium on the latest developments in #scleroderma research and multidisciplinary management. 

Anthony…

Primary Raynaud's is not correlated with any underlying medical condition, whereas secondary Raynaud's is causally connected to another medical condition, such as #scleroderma or #lupus. Read more, here: bit.ly/3bL8xkT #raynaudsphenomenon #frosties


#Scleroderma La thérapie par cellules CAR-T atténue les symptômes de la sclérodermie systémique, selon les premières données d'un essai clinique sclerodermanews.com/news/car-t-cel…


Congratulations to Dr. Zsuzsanna McMahan on her award from Promote Altruism! This is supporting her critical work in the field of the debilitating GI manifestations of #scleroderma . Thank you for all you do for your patients! #rheumatology

UTHealthRheum's tweet image. Congratulations to Dr. Zsuzsanna McMahan on her award from Promote Altruism! This is supporting her critical work in the field of the debilitating GI manifestations of #scleroderma . Thank you for all you do for your patients! #rheumatology

``` 🚨 VEDOSS = EARLY #Scleroderma ✅ Must: Raynaud’s + ≥1 Red Flag 🔴 Puffy fingers → early swelling 🔴 +ve ANA (centromere/speckled) 🔴 Abnormal capillaroscopy 🔴 SSc antibodies (ACA, topo, RNA pol) ⚠️ ≥3 flags = 80–90% → SSc in 5 yrs Screen NOW! #scleroderma


✨How can we better understand and treat fibrotic diseases? Meet Dr. Dinesh Khanna at #ECM2026. @sclerodermaUM He is a Professor of Medicine and Director of the University of Michigan (@UMich) Scleroderma Program , pioneering precision research in #scleroderma and #fibrosis.

ecmcongress's tweet image. ✨How can we better understand and treat fibrotic diseases? 

Meet Dr. Dinesh Khanna at #ECM2026. @sclerodermaUM 

He is a Professor of Medicine and Director of the University of Michigan (@UMich) Scleroderma Program , pioneering precision research in #scleroderma and #fibrosis.

Primary Raynaud's is not correlated with any underlying medical condition, whereas secondary Raynaud's is causally connected to another medical condition, such as #scleroderma or #lupus. Read more, here: bit.ly/3bL8xkT #raynaudsphenomenon #frosties


#ACR25 Unlike other CTDs, #scleroderma -diagnosis a little bit later -few of patients (but not none) desire pregnancy this study show: Fetal and maternal outcomes in #systemicsclerosis pregnancies, are not big issue. This is promising for SSc acrabstracts.org/abstract/fetal…


🏆 Meet the 2025 Major & Starting Grant winners from @WSF_Scleroderma! 👏 Their work drives research & hope for the #Scleroderma community. 🎧 Listen to Voices from SSc – Ep.1 🔗 Register free: worldsclerofound.org/register/ #WSFAcademy #SSc #Research #ILD

Worldsclerofnd's tweet image. 🏆 Meet the 2025 Major & Starting Grant winners from @WSF_Scleroderma!
👏 Their work drives research & hope for the #Scleroderma community.
🎧 Listen to Voices from SSc – Ep.1
🔗 Register free: worldsclerofound.org/register/
#WSFAcademy #SSc #Research #ILD
Worldsclerofnd's tweet image. 🏆 Meet the 2025 Major & Starting Grant winners from @WSF_Scleroderma!
👏 Their work drives research & hope for the #Scleroderma community.
🎧 Listen to Voices from SSc – Ep.1
🔗 Register free: worldsclerofound.org/register/
#WSFAcademy #SSc #Research #ILD

Exploring the intersection of #Scleroderma and #GAVE — uncovering key demographic and mortality trends from a national inpatient analysis. Honored to share our findings at #ACR2025! #RheumResearch

akanksha0411's tweet image. Exploring the intersection of #Scleroderma and #GAVE — uncovering key demographic and mortality trends from a national inpatient analysis. Honored to share our findings at #ACR2025! #RheumResearch

UT Houston #Rheumatology division welcomes Dr. Jörg Distler who shared his incredible work regarding molecular profiling of fibroblasts in #scleroderma. Thank you for your insights and all of your efforts!

UTHealthRheum's tweet image. UT Houston #Rheumatology division welcomes Dr. Jörg Distler who shared his incredible work regarding molecular profiling of fibroblasts in #scleroderma. Thank you for your insights and all of your efforts!
UTHealthRheum's tweet image. UT Houston #Rheumatology division welcomes Dr. Jörg Distler who shared his incredible work regarding molecular profiling of fibroblasts in #scleroderma. Thank you for your insights and all of your efforts!

Hey everyone! Today is #WorldSclerodermaDay I’m raising awareness about this debilitating disease! I’m in my 4th year. Don’t give up hope! We will find a cure. I’m happy to be thriving. Thanks for the love! ❤️🙏🏼#scleroderma

ClaireDeVille3's tweet image. Hey everyone! Today is #WorldSclerodermaDay I’m raising awareness about this debilitating disease! I’m in my 4th year. Don’t give up hope! We will find a cure. I’m happy to be thriving. Thanks for the love! ❤️🙏🏼#scleroderma

Biologic Therapy for Refractory Juvenile Scleroderma” by Dr. Munirah Al Marri was accepted at #ACR25 – Chicago 🇺🇸! The world’s main rheumatology conference, covering both adult & pediatric advances. A proud step forward in improving care for young patients. #Scleroderma

Drasiri1000's tweet image. Biologic Therapy for Refractory Juvenile Scleroderma” by Dr. Munirah Al Marri
was accepted at #ACR25 – Chicago 🇺🇸!

The world’s main rheumatology conference, covering both adult & pediatric advances.
A proud step forward in improving care for young patients. 

#Scleroderma…

While NSIP & UIP are common patterns on HRCT, COP, LIP & DIP can occur in #Scleroderma-ILD. Neither NSIP nor UIP are independent predators of survival. @HanaRheum #EULAR2025

SindhuJohnson5's tweet image. While NSIP & UIP are common patterns on HRCT, COP, LIP & DIP can occur in #Scleroderma-ILD. Neither NSIP nor UIP are independent predators of survival. @HanaRheum #EULAR2025

#Scleroderma specific autoantibodies in predicting prognosis/survival ➡️ almost all #ANA positive 📈 Best survival in anticentromere group 📉 Diffuse subtype carries a worse prognosis especially Anti-Scl70, anti-RNA polymerase III & If 🫁 ILD present [AL Herrick]

LastManStand85's tweet image. #Scleroderma specific autoantibodies in predicting prognosis/survival 

➡️ almost all #ANA positive

📈 Best survival in anticentromere group
 
📉 Diffuse subtype carries a worse prognosis especially Anti-Scl70, anti-RNA polymerase III & If 🫁 ILD present 

[AL Herrick]

Great @SmidtHeart #research seminar by X. Mike Jones. Lead #ncRNA compound TY1 reverses the key manifestations of #scleroderma in two complementary mouse models! It even works orally. Next goal: first-in-human studies in #systemicsclerosis patients! @CedarsSinaiMed

MarbanLab's tweet image. Great @SmidtHeart #research seminar by X. Mike Jones. Lead #ncRNA compound TY1 reverses the key manifestations of #scleroderma in two complementary mouse models! It even works orally. Next goal: first-in-human studies in #systemicsclerosis patients!
@CedarsSinaiMed

Dr. Aos Aboabat, #Scleroderma Clinical Research Fellow @SchroederInst, supervised by Dr. @SindhuJohnson5, presented his research at the Rheumatology Ogryzlo Research Day @UofT and will be graduating this year!  #WorldSclerodermaDay

SchroederInst's tweet image. Dr. Aos Aboabat, #Scleroderma Clinical Research Fellow @SchroederInst, supervised by Dr. @SindhuJohnson5, presented his research at the Rheumatology Ogryzlo Research Day @UofT and will be graduating this year!  #WorldSclerodermaDay
SchroederInst's tweet image. Dr. Aos Aboabat, #Scleroderma Clinical Research Fellow @SchroederInst, supervised by Dr. @SindhuJohnson5, presented his research at the Rheumatology Ogryzlo Research Day @UofT and will be graduating this year!  #WorldSclerodermaDay

Outstanding talk on #scleroderma and Nail fold video capillaroscopy by @AshimaMakol @MayoClinic #STIR24

MdWarrington's tweet image. Outstanding talk on #scleroderma and Nail fold video capillaroscopy by @AshimaMakol @MayoClinic 

#STIR24
MdWarrington's tweet image. Outstanding talk on #scleroderma and Nail fold video capillaroscopy by @AshimaMakol @MayoClinic 

#STIR24
MdWarrington's tweet image. Outstanding talk on #scleroderma and Nail fold video capillaroscopy by @AshimaMakol @MayoClinic 

#STIR24

Bang-up @MarbanLab mtg presentation by @nih_nhlbi #T32 fellow @XMichaelJonesMD gives new hope for #scleroderma. In two #mouse models and human #SSc #macrophages (🙏@fboinMD), #ncRNA drug TY1 attenuates #DNAdamage and reverses disease. 👍. Thanks Mike for your great work!…

MarbanLab's tweet image. Bang-up @MarbanLab mtg presentation by @nih_nhlbi #T32 fellow @XMichaelJonesMD gives new hope for #scleroderma. In two #mouse models and human #SSc #macrophages (🙏@fboinMD), #ncRNA drug TY1 attenuates #DNAdamage and reverses disease. 👍. Thanks Mike for your great work!…
MarbanLab's tweet image. Bang-up @MarbanLab mtg presentation by @nih_nhlbi #T32 fellow @XMichaelJonesMD gives new hope for #scleroderma. In two #mouse models and human #SSc #macrophages (🙏@fboinMD), #ncRNA drug TY1 attenuates #DNAdamage and reverses disease. 👍. Thanks Mike for your great work!…
MarbanLab's tweet image. Bang-up @MarbanLab mtg presentation by @nih_nhlbi #T32 fellow @XMichaelJonesMD gives new hope for #scleroderma. In two #mouse models and human #SSc #macrophages (🙏@fboinMD), #ncRNA drug TY1 attenuates #DNAdamage and reverses disease. 👍. Thanks Mike for your great work!…
MarbanLab's tweet image. Bang-up @MarbanLab mtg presentation by @nih_nhlbi #T32 fellow @XMichaelJonesMD gives new hope for #scleroderma. In two #mouse models and human #SSc #macrophages (🙏@fboinMD), #ncRNA drug TY1 attenuates #DNAdamage and reverses disease. 👍. Thanks Mike for your great work!…

2 years ago,I was invited onto @BBCSheffield Paulette's show to talk about my #scleroderma I've kindly been invited back on to talk about allsorts this Wednesday morning! Wish me luck !!

sclerodermasara's tweet image. 2 years ago,I was invited onto @BBCSheffield Paulette's show to talk about my #scleroderma 
I've kindly been invited back on to talk about allsorts this Wednesday morning! Wish me luck !!

On #WorldSclerodermaDay let's spread awareness about #Scleroderma! Early diagnosis focuses on detecting symptomatic patients as early as possibile, it is the key to make a significant difference in treatment outcomes!

EmanuelaPraino's tweet image. On #WorldSclerodermaDay let's spread awareness about #Scleroderma! Early diagnosis focuses on detecting symptomatic patients as early as possibile, it is the key to make a significant difference in treatment outcomes!

#scleroderma 1. why is SSc- a 'fibrotic disease' treated with immunosuppressive? 2. Why dont every patient with early SSc respond to immunosuppressive? the lessons lie in understanding the underlying mechanisms of early SSc and molecular heterogeneity. @IRACON24Blr

sclerodermaUM's tweet image. #scleroderma 
1. why is SSc- a 'fibrotic disease' treated with immunosuppressive?
2. Why dont every patient with early SSc respond to immunosuppressive? 
the lessons lie in understanding the underlying mechanisms of early SSc and molecular heterogeneity.  @IRACON24Blr
sclerodermaUM's tweet image. #scleroderma 
1. why is SSc- a 'fibrotic disease' treated with immunosuppressive?
2. Why dont every patient with early SSc respond to immunosuppressive? 
the lessons lie in understanding the underlying mechanisms of early SSc and molecular heterogeneity.  @IRACON24Blr

Prophylactic ACEi in #Scleroderma? No benefit, worse outcomes in renal crisis! #Rheumatology #MedTwitter #BSR25

LastManStand85's tweet image. Prophylactic ACEi in #Scleroderma?

No benefit, worse outcomes in renal crisis!

#Rheumatology #MedTwitter #BSR25

#OTWeek2023 "It sounds daft doesn't it...but that's the thing I most want to be able to do again" How would you feel if you couldn't hold a cup of tea to enjoy a brew? Working with this #scleroderma patient to find a mug that he can hold himself @SalfordCO_NHS @RCOT_TMH @theRCOT

CathMcCoy's tweet image. #OTWeek2023
"It sounds daft doesn't it...but that's the thing I most want to be able to do again"
How would you feel if you couldn't hold a cup of tea to enjoy a brew? Working with this #scleroderma patient to find a mug that he can hold himself @SalfordCO_NHS @RCOT_TMH @theRCOT

🆕CD19 CAR T Cell treatment -A potentially promising future treatment in #SLE #scleroderma #myositis -Needs close collaboration with haematology Great explanation by @chriswincup #ACR24 #Lupus #SystemicSclerosis #IIM

gurdeep_dulay's tweet image. 🆕CD19 CAR T Cell treatment

-A potentially promising future treatment in #SLE #scleroderma #myositis 

-Needs close collaboration with haematology

Great explanation by @chriswincup #ACR24  #Lupus #SystemicSclerosis #IIM

My dear son in law. Waiting for #lungtransplant #scleroderma #VGH grateful to donors grateful to doctors

karen_kelowna's tweet image. My dear son in law. Waiting for #lungtransplant #scleroderma
#VGH grateful to donors grateful to doctors

Loading...

Something went wrong.


Something went wrong.


United States Trends